Copernicus Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Copernicus Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-11,327	Closed	-$703K	–	16
2020 Q4	$703K	Sell	11,327 -201,987	-95%	-$12.4M	10.96%	3
2020 Q3	$12.9M	Buy	213,314 +41,821	+24%	+$2.52M	12.25%	2
2020 Q2	$10.1M	Sell	171,493 -5,504	-3%	-$329K	11.05%	2
2020 Q1	$9.87M	Buy	176,997 +44,165	+33%	+$2.7M	11.94%	2
2019 Q4	$8.53M	Sell	132,832 -65,105	-33%	-$3.73M	11.18%	3
2019 Q3	$10M	Sell	197,937 -45,000	-19%	-$2.11M	9.34%	3
2019 Q2	$11M	Buy	242,937 +157,937	+186%	+$7.36M	9.8%	3
2019 Q1	$4.05M	Buy	+85,000	New	+$4.23M	10.4%	3

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Copernicus Capital Management's BMY Position: Q1 2021 in Review

Copernicus Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 11,327 shares — an estimated $703K sold.

Copernicus Capital Management first reported a position in BMY in Q1 2019 and held it in 8 quarters. The position peaked at $12.9M in Q3 2020. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

Copernicus Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
Copernicus Capital Management sold 11,327 Bristol-Myers Squibb shares in Q1 2021, an estimated $703K.
Copernicus Capital Management first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 8 quarters.
Copernicus Capital Management's Bristol-Myers Squibb position peaked at $12.9M in Q3 2020.
2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Copernicus Capital Management's 13F filing for Q1 2021, filed 17 May 2021.